Cripto-1: An Oncofetal Gene with Many Faces

Current Topics in Developmental Biology

Volumn 67, Issue , 2005, Pages 85-133

  Bianco, Caterina ^a   Strizzi, Luigi ^a   Normanno, Nicola ^b   Khan, Nadia ^a   Salomon, David S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33646154655     PISSN: 00702153     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0070-2153(05)67003-2     Document Type: Chapter

References (214)

1. Aaronson S.A. Growth factors and cancer. Science 254 (1991) 1146-1153
2. Abdel-Ghany M., Cheng H.C., Elble R.C., and Pauli B.U. The breast cancer beta 4 integrin and endothelial human CLCA2 mediate lung metastasis. J. Biol. Chem. 276 (2001) 25438-25446
3. Abe S., Sasano H., Katoh K., Ohara S., Arikawa T., Noguchi T., Asaki S., Yasui W., Tahara E., Nagura H., and Toyota T. Immunohistochemical studies on EGF family growth factors in normal and ulcerated human gastric mucosa. Dig. Dis. Sci. 42 (1997) 1199-1209
4. Ackland M.L., Newgreen D.F., Fridman M., Waltham M.C., Arvanitis A., Minichiello J., Price J.T., and Thompson E.W. Epidermal growth factor-induced epithelio-mesenchymal transition in human breast carcinoma cells. Lab. Invest. 83 (2003) 435-448
5. Adamson E.D., Minchiotti G., and Salomon D.S. Cripto: A tumor growth factor and more. J. Cell. Physiol. 190 (2002) 267-278
6. Adkins H.B., Bianco C., Schiffer S.G., Rayhorn P., Zafari M., Cheung A.E., Orozco O., Olson D., De Luca A., Chen L.L., Miatkowski K., Benjamin C., Normanno N., Williams K.P., Jarpe M., LePage D., Salomon D., and Sanicola M. Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo. J. Clin. Invest. 112 (2003) 575-587
7. Agrawal S., and Zhao Q. Mixed backbone oligonucleotides: Improvement in oligonucleotide-induced toxicity in vivo. Antisense Nucleic Acid Drug Dev. 8 (1998) 135-139
8. Alexander R.J., Panja A., Kaplan-Liss E., Mayer L., and Raicht R.F. Expression of growth factor receptor-encoded mRNA by colonic epithelial cells is altered in inflammatory bowel disease. Dig. Dis. Sci. 40 (1995) 485-494
9. Ayhan A., Tuncer Z.S., Ruacan S., Yasui W., and Tahara E. Abnormal expression of cripto and p53 protein in endometrial carcinoma and its precursor lesions. Eur. J. Gynaecol. Oncol. 19 (1998) 316-318
10. Baldassarre G., Romano A., Armenante F., Rambaldi M., Paoletti I., Sandomenico C., Pepe S., Staibano S., Salvatore G., De Rosa G., Persico M.G., and Viglietto G. Expression of teratocarcinoma-derived growth factor-1 (TDGF-1) in testis germ cell tumors and its effects on growth and differentiation of embryonal carcinoma cell line NTERA2/D1. Oncogene 15 (1997) 927-936
11. Baldassarre G., Tucci M., Lembo G., Pacifico F.M., Dono R., Lago C.T., Barra A., Bianco C., Viglietto G., Salomon D., and Persico M.G. A truncated form of teratocarcinoma-derived growth factor-1 (cripto-1) mRNA expressed in human colon carcinoma cell lines and tumors. Tumour Biol. 22 (2001) 286-293
12. Bamford R.N., Roessler E., Burdine R.D., Saplakoglu U., de la Cruz J., Splitt M., Goodship J.A., Towbin J., Bowers P., Ferrero G.B., Marino B., Schier A.F., Shen M.M., Muenke M., and Casey B. Loss-of-function mutations in the EGF-CFC gene CFC1 are associated with human left-right laterality defects. Nat. Genet. 26 (2000) 365-369
13. Barcellos-Hoff M.H., and Ewan K.B. Transforming growth factor-beta and breast cancer: Mammary gland development. Breast Cancer Res. 2 (2000) 92-99
14. Beauvais D.M., and Rapraeger A.C. Syndecan-1-mediated cell spreading requires signaling by alphavbeta3 integrins in human breast carcinoma cells. Exp. Cell. Res. 286 (2003) 219-232
15. Beddington R.S., and Robertson E.J. Axis development and early asymmetry in mammals. Cell 96 (1999) 195-209
16. Bianco C., Kannan S., De Santis M., Seno M., Tang C.K., Martinez-Lacaci I., Kim N., Wallace-Jones B., Lippman M.E., Ebert A.D., Wechselberger C., and Salomon D.S. Cripto-1 indirectly stimulates the tyrosine phosphorylation of erb B-4 through a novel receptor. J. Biol. Chem. 274 (1999) 8624-8629
17. Bianco C., Wechselberger C., Ebert A., Khan N.I., Sun Y., and Salomon D.S. Identification of Cripto-1 in human milk. Breast Cancer Res. Treat. 66 (2001) 1-7
18. Bianco C., Adkins H.B., Wechselberger C., Seno M., Normanno N., De Luca A., Sun Y., Khan N., Kenney N., Ebert A., Williams K.P., Sanicola M., and Salomon D.S. Cripto-1 activates nodal- and ALK4-dependent and -independent signaling pathways in mammary epithelial cells. Mol. Cell. Biol. 22 (2002) 2586-2597
19. Bianco C., Normanno N., De Luca A., Maiello M.R., Wechselberger C., Sun Y., Khan N., Adkins H., Sanicola M., Vonderhaar B., Cohen B., Seno M., and Salomon D. Detection and localization of Cripto-1 binding in mouse mammary epithelial cells and in the mouse mammary gland using an immunoglobulin-cripto-1 fusion protein. J. Cell. Physiol. 190 (2002) 74-82
20. Bianco C., Strizzi L., Rehman A., Normanno N., Wechselberger C., Sun Y., Khan N., Hirota M., Adkins H., Williams K., Margolis R.U., Sanicola M., and Salomon D.S. A Nodal- and ALK4-independent signaling pathway activated by Cripto-1 through Glypican-1 and c-Src. Cancer Res. 63 (2003) 1192-1197
21. Borellini F., and Oka T. Growth control and differentiation in mammary epithelial cells. Environ. Health Perspect. 80 (1989) 85-99
22. Boyer B., Valles A.M., and Edme N. Induction and regulation of epithelial-mesenchymal transitions. Biochem. Pharmacol. 60 (2000) 1091-1099
23. Brandt R., Normanno N., Gullick W.J., Lin J.H., Harkins R., Schneider D., Jones B.W., Ciardiello F., Persico M.G., Armenante F., et al. Identification and biological characterization of an epidermal growth factor-related protein: Cripto-1. J. Biol. Chem. 269 (1994) 17320-17328
24. Branford W.W., and Yost H.J. Lefty-dependent inhibition of Nodal- and Wnt-responsive organizer gene expression is essential for normal gastrulation. Curr. Biol. 12 (2002) 2136-2141
25. Brennan J., Lu C.C., Norris D.P., Rodriguez T.A., Beddington R.S., and Robertson E.J. Nodal signaling in the epiblast patterns the early mouse embryo. Nature 411 (2001) 965-969
26. Burridge K., Turner C.E., and Romer L.H. Tyrosine phosphorylation of paxillin and pp125FAK accompanies cell adhesion to extracellular matrix: A role in cytoskeletal assembly. J. Cell. Biol. 119 (1992) 893-903
27. Byrne R.L., Autzen P., Birch P., Robinson M.C., Gullick W.J., Neal D.E., and Hamdy F.C. The immunohistochemical detection of cripto-1 in benign and malignant human bladder. J. Pathol. 185 (1998) 108-111
28. Calhoun J.D., Rao R.R., Warrenfeltz S., Rekaya R., Dalton S., McDonald J., and Stice S.L. Transcriptional profiling of initial differentiation events in human embryonic stem cells. Biochem. Biophys. Res. Commun. 323 (2004) 453-464
29. Callahan R. MMTV-induced mutations in mouse mammary tumors: Their potential relevance to human breast cancer. Breast Cancer Res. Treat. 39 (1996) 33-44
30. Casamassimi A., De Luca A., Agrawal S., Stromberg K., Salomon D.S., and Normanno N. EGF-related antisense oligonucleotides inhibit the proliferation of human ovarian carcinoma cells. Ann. Oncol. 11 (2000) 319-325
31. Casaroli-Marano R.P., Pagan R., and Vilaro S. Epithelial-mesenchymal transition in proliferative vitreoretinopathy: Intermediate filament protein expression in retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 40 (1999) 2062-2072
32. Cavallaro U., and Christofori G. Molecular mechanisms of tumor angiogenesis and tumor progression. Ann. N. Y. Acad. Sci. 1014 (2004) 58-66
33. Chen C., and Shen M.M. Two modes by which Lefty proteins inhibit nodal signaling. Curr. Biol. 14 (2004) 618-624
34. Chen Y., and Schier A.F. Lefty proteins are long-range inhibitors of squint-mediated nodal signaling. Curr. Biol. 12 (2002) 2124-2128
35. Chen Y., Mironova E., Whitaker L.L., Edwards L., Yost H.J., and Ramsdell A.F. ALK4 functions as a receptor for multiple TGF beta-related ligands to regulate left-right axis determination and mesoderm induction in Xenopus. Dev. Biol. 268 (2004) 280-294
36. Cheng S.K., Olale F., Bennett J.T., Brivanlou A.H., and Schier A.F. EGF-CFC proteins are essential coreceptors for the TGF-beta signals Vg1 and GDF1. Genes. Dev. 17 (2003) 31-36
37. Cheng S.K., Olale F., Brivanlou A.H., and Schier A.F. Lefty blocks a subset of TGFbeta signals by antagonizing EGF-CFC coreceptors. PLoS. Biol. 2 (2004) E30
38. Ciardiello F., Valverius E.M., Colucci-D'Amato G.L., Kim N., Bassin R.H., and Salomon D.S. Differential growth factor expression in transformed mouse NIH-3T3 cells. J. Cell. Biochem. 42 (1990) 45-57
39. Ciardiello F., Dono R., Kim N., Persico M.G., and Salomon D.S. Expression of cripto, a novel gene of the epidermal growth factor gene family, leads to in vitro transformation of a normal mouse mammary epithelial cell line. Cancer Res. 51 (1991) 1051-1054
40. Ciardiello F., Kim N., Saeki T., Dono R., Persico M.G., Plowman G.D., G., J., Radke S., Todaro G.J., and Salomon D.S. Differential expression of epidermal growth factor-related proteins in human colorectal tumors. Proc. Natl. Acad. Sci. USA 88 (1991) 7792-7796
41. Ciardiello F., Tortora G., Bianco C., Selvam M.P., Basolo F., Fontanini G., Pacifico F., Normanno N., Brandt R., Persico M.G., et al. Inhibition of CRIPTO expression and tumorigenicity in human colon cancer cells by antisense RNA and oligodeoxynucleotides. Oncogene 9 (1994) 291-298
42. Ciccodicola A., Dono R., Obici S., Simeone A., Zollo M., and Persico M.G. Molecular characterization of a gene of the "EGF family" expressed in undifferentiated human NTERA2 teratocarcinoma cells. EMBO J. 8 (1989) 1987-1991
43. Colas J.F., and Schoenwolf G.C. Subtractive hybridization identifies chick-cripto, a novel EGF-CFC ortholog expressed during gastrulation, neurulation, and early cardiogenesis. Gene 255 (2000) 205-217
44. Crawford H.C., Fingleton B.M., Rudolph-Owen L.A., Goss K.J., Rubinfeld B., Polakis P., and Matrisian L.M. The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors. Oncogene 18 (1999) 2883-2891
45. D'Antonio A., Losito S., Pignata S., Grassi M., Perrone F., De Luca A., Tambaro R., Bianco C., Gullick W.J., Johnson G.R., Iaffaioli V.R., Salomon D.S., and Normanno N. Transforming growth factor alpha, amphiregulin, and cripto-1 are frequently expressed in advanced human ovarian carcinomas. Int. J. Oncol. 21 (2002) 941-948
46. Dandachi N., Hauser-Kronberger C., More E., Wiesener B., Hacker G.W., Dietze O., and Wirl G. Co-expression of tenascin-C and vimentin in human breast cancer cells indicates phenotypic transdifferentiation during tumor progression: Correlation with histopathological parameters, hormone receptors, and oncoproteins. J. Pathol. 193 (2001) 181-189
47. Danen E.H., and Sonnenberg A. Integrins in regulation of tissue development and function. J. Pathol. 201 (2003) 632-641
48. Daniel C.W., and Silberstein G.B. Postnatal development of the rodent mammary gland. In: Neville M.C., and Daniel C.W. (Eds). "The Mammary Gland: Development, Regulation, and Function" (1987), Plenum Press, New York 3-36
49. Daniel C.W., Robinson S., and Silberstein G.B. The transforming growth factors beta in development and functional differentiation of the mouse mammary gland. Adv. Exp. Med. Biol. 501 (2001) 61-70
50. De Angelis E., Grassi M., Gullick W.J., Johnson G.R., Rossi G.B., Tempesta A., De Angelis F., De Luca A., Salomon D.S., and Normanno N. Expression of cripto and amphiregulin in colon mucosa from high risk colon cancer families. Int. J. Oncol. 14 (1999) 437-440
51. de la Cruz J.M., Bamford R.N., Burdine R.D., Roessler E., Barkovich A.J., Donnai D., Schier A.F., and Muenke M. A loss-of-function mutation in the CFC domain of TDGF1 is associated with human forebrain defects. Hum. Genet. 110 (2002) 422-428
52. De Luca A., Selvam M.P., Sandomenico C., Pepe S., Bianco A.R., Ciardiello F., Salomon D.S., and Normanno N. Anti-sense oligonucleotides directed against EGF-related growth factors enhance anti-proliferative effect of conventional anti-tumor drugs in human colon-cancer cells. Int. J. Cancer 73 (1997) 277-282
53. De Luca A., Casamassimi A., Selvam M.P., Losito S., Ciardiello F., Agrawal S., Salomon D.S., and Normanno N. EGF-related peptides are involved in the proliferation and survival of MDA-MB-468 human breast carcinoma cells. Int. J. Cancer 80 (1999) 589-594
54. De Luca A., Arra C., D'Antonio A., Casamassimi A., Losito S., Ferraro P., Ciardiello F., Salomon D.S., and Normanno N. Simultaneous blockage of different EGF-like growth factors results in efficient growth inhibition of human colon carcinoma xenografts. Oncogene 19 (2000) 5863-5871
55. De Santis M.L., Kannan S., Smith G.H., Seno M., Bianco C., Kim N., Martinez-Lacaci I., Wallace-Jones B., and Salomon D.S. Cripto-1 inhibits beta-casein expression in mammary epithelial cells through a p21ras- and phosphatidylinositol 3′-kinase-dependent pathway. Cell Growth Differ. 8 (1997) 1257-1266
56. De Santis M.L., Martinez-Lacaci I., Bianco C., Seno M., Wallace-Jones B., Kim N., Ebert A., Wechselberger C., and Salomon D.S. Cripto-1 induces apoptosis in HC-11 mouse mammary epithelial cells. Cell Death. Differ. 7 (2000) 189-196
57. Dean N.M., and Bennett C.F. Antisense oligonucleotide-based therapeutics for cancer. Oncogene 22 (2003) 9087-9096
58. Ding J., Yang L., Yan Y.T., Chen A., Desai N., Wynshaw-Boris A., and Shen M.M. Cripto is required for correct orientation of the anterior-posterior axis in the mouse embryo. Nature 395 (1998) 702-707
59. Dono R., Montuori N., Rocchi M., De Ponti-Zilli L., Ciccodicola A., and Persico M.G. Isolation and characterization of the CRIPTO autosomal gene and its X-linked related sequence. Am. J. Hum. Genet. 49 (1991) 555-565
60. Dono R., Scalera L., Pacifico F., Acampora D., Persico M.G., and Simeone A. The murine cripto gene: Expression during mesoderm induction and early heart morphogenesis. Development 118 (1993) 1157-1168
61. Dublin E.A., Bobrow L.G., Barnes D.M., and Gullick W.J. Amphiregulin and cripto-1 overexpression in breast cancer: Relationship with prognosis and clinical and molecular variables. Int. J. Onc. 7 (1995) 617-622
62. Duboc V., Rottinger E., Besnardeau L., and Lepage T. Nodal and BMP2/4 signaling organizes the oral-aboral axis of the sea urchin embryo. Dev. Cell 6 (2004) 397-410
63. Ebert A.D., Wechselberger C., Frank S., Wallace-Jones B., Seno M., Martinez-Lacaci I., Bianco C., De Santis M., Weitzel H.K., and Salomon D.S. Cripto-1 induces phosphatidylinositol 3′-kinase-dependent phosphorylation of AKT and glycogen synthase kinase 3beta in human cervical carcinoma cells. Cancer Res. 59 (1999) 4502-4505
64. Ebert A.D., Wechselberger C., Nees M., Clair T., Schaller G., Martinez-Lacaci I., Wallace-Jones B., Bianco C., Weitzel H.K., and Salomon D.S. Cripto-1-induced increase in vimentin expression is associated with enhanced migration of human Caski cervical carcinoma cells. Exp. Cell. Res. 257 (2000) 223-229
65. Ertoy D., Ayhan A., Sarac E., Karaagaoglu E., Yasui W., and Tahara E. Clinicopathological implication of cripto expression in early stage invasive cervical carcinomas. Eur. J. Cancer 36 (2000) 1002-1007
66. Foley S.F., van Vlijmen H.W., Boynton R.E., Adkins H.B., Cheung A.E., Singh J., Sanicola M., Young C.N., and Wen D. The CRIPTO/FRL-1/CRYPTIC (CFC) domain of human Cripto. Functional and structural insights through disulfide structure analysis. Eur. J. Biochem. 270 (2003) 3610-3618
67. Fontanini G., De Laurentiis M., Vignati S., Chine S., Lucchi M., Silvestri V., Mussi A., De Placido S., Tortora G., Bianco A.R., Gullick W., Angeletti C.A., Bevilacqua G., and Ciardiello F. Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: Amphiregulin and microvessel count are independent prognostic indicators of survival. Clin. Cancer Res. 4 (1998) 241-249
68. Fraser S.E., and Harland R.M. The molecular metamorphosis of experimental embryology. Cell 100 (2000) 41-55
69. Friess H., Yamanaka Y., Buchler M., Kobrin M.S., Tahara E., and Korc M. Cripto, a member of the epidermal growth factor family, is overexpressed in human pancreatic cancer and chronic pancreatitis. Int. J. Cancer 56 (1994) 668-674
70. Fujii K., Yasui W., Kuniyasu H., Itoh M., Hanada K., Kajiyama G., and Tahara E. Expression of cripto in human gall bladder lesions. J. Pathol. 180 (1996) 166-168
71. Gagliardi G., Talbot I.C., Northover J.M.A., Warre A., Stamp G.W.H., Lalani E.-N., Gullick W.J., and Pignatelli M. Immunolocalization of cripto and amphizegulin in rectal cancer: Correlation with prognosis. Int. J. Oncol. 4 (1994) 865-871
72. Gaio U., Schweickert A., Fischer A., Garratt A.N., Muller T., Ozcelik C., Lankes W., Strehle M., Britsch S., Blum M., and Birchmeier C. A role of the cryptic gene in the correct establishment of the left-right axis. Curr. Biol. 9 (1999) 1339-1342
73. Gilboa L., and Lehmann R. Repression of primordial germ cell differentiation parallels germ line stem cell maintenance. Curr. Biol. 14 (2004) 981-986
74. Goustin A.S., Leof E.B., Shipley G.D., and Moses H.L. Growth factors and cancer. Cancer Res. 46 (1986) 1015-1029
75. Gray P.C., Harrison C.A., and Vale W. Cripto forms a complex with activin and type II activin receptors and can block activin signaling. Proc. Natl. Acad. Sci. USA 100 (2003) 5193-5198
76. Griffin K.J., and Kimelman D. One-Eyed Pinhead and Spadetail are essential for heart and somite formation. Nat. Cell. Biol. 4 (2002) 821-825
77. Grille S.J., Bellacosa A., Upson J., Klein-Szanto A.J., van Roy F., Lee-Kwon W., Donowitz M., Tsichlis P.N., and Larue L. The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res. 63 (2003) 2172-2178
78. Gritsman K., Zhang J., Cheng S., Heckscher E., Talbot W.S., and Schier A.F. The EGF-CFC protein one-eyed pinhead is essential for nodal signaling. Cell 97 (1999) 121-132
79. Guy C.T., Cardiff R.D., and Muller W.J. Induction of mammary tumors by expression of polyomavirus middle T oncogene: A transgenic mouse model for metastatic disease. Mol. Cell. Biol. 12 (1992) 954-961
80. Haltiwanger R.S., and Stanley P. Modulation of receptor signaling by glycosylation: Fringe is an O-fucose-beta1,3-N-acetylglucosaminyltransferase. Biochim. Biophys. Acta 1573 (2002) 328-335
81. Haltiwanger R.S., and Lowe J.B. Role of glycosylation in development. Annu. Rev. Biochem. 73 (2004) 491-537
82. Hamada H., Meno C., Watanabe D., and Saijoh Y. Establishment of vertebrate left-right asymmetry. Nat. Rev. Genet. 3 (2002) 103-113
83. Haramoto Y., Tanegashima K., Onuma Y., Takahashi S., Sekizaki H., and Asashima M. Xenopus tropicalis nodal-related gene 3 regulates BMP signaling: An essential role for the pro-region. Dev. Biol. 265 (2004) 155-168
84. Harms P.W., and Chang C. Tomoregulin-1 (TMEFF1) inhibits nodal signaling through direct binding to the nodal coreceptor Cripto. Genes Dev. 17 (2003) 2624-2629
85. Haruma K., Ito M., Kohmoto K., Kamada T., Kitada Y., Yasui W., Tahara E., and Kajiyama G. Expression of cell cycle regulators and growth factor/receptor systems in gastric carcinoma in young adults: Association with Helicobacter pylori infection. Int. J. Mol. Med. 5 (2000) 185-190
86. Haslam S.Z., and Woodward T.L. Reciprocal regulation of extracellular matrix proteins and ovarian steroid activity in the mammary gland. Breast Cancer Res. 3 (2001) 365-372
87. Hazan R.B., Phillips G.R., Qiao R.F., Norton L., and Aaronson S.A. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J. Cell. Biol. 148 (2000) 779-790
88. Henderson B.R., and Fagotto F. The ins and outs of APC and beta-catenin nuclear transport. EMBO Rep. 3 (2002) 834-839
89. Herrington E.E., Ram T.G., Salomon D.S., Johnson G.R., Gullick W.J., Kenney N., and Hosick H.L. Expression of epidermal growth factor-related proteins in the aged adult mouse mammary gland and their relationship to tumorigenesis. J. Cell. Physiol. 170 (1997) 47-56
90. Howlett A.R., and Bissell M.J. The influence of tissue microenvironment (stroma and extracellular matrix) on the development and function of mammary epithelium. Epithelial Cell. Biol. 2 (1993) 79-89
91. Islam S., Carey T.E., Wolf G.T., Wheelock M.J., and Johnson K.R. Expression of N-cadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell-cell adhesion. J. Cell. Biol. 135 (1996) 1643-1654
92. Jhappan C., Stahle C., Harkins R.N., Fausto N., Smith G.H., and Merlino G.T. TGF alpha overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 61 (1990) 1137-1146
93. Jhappan C., Gallahan D., Stahle C., Chu E., Smith G.H., Merlino G., and Callahan R. Expression of an activated Notch-related int-3 transgene interferes with cell differentiation and induces neoplastic transformation in mammary and salivary glands. Genes Dev. 6 (1992) 345-355
94. Johnson S.E., Rothstein J.L., and Knowles B.B. Expression of epidermal growth factor family gene members in early mouse development. Dev. Dyn. 201 (1994) 216-226
95. Jornvall H., Blokzijl A., ten Dijke P., and Ibanez C.F. The orphan receptor serine/threonine kinase ALK7 signals arrest of proliferation and morphological differentiation in a neuronal cell line. J. Biol. Chem. 276 (2001) 5140-5146
96. Kannan S., De Santis M., Lohmeyer M., Riese II D.J., Smith G.H., Hynes N., Seno M., Brandt R., Bianco C., Persico G., Kenney N., Normanno N., Martinez-Lacaci I., Ciardiello F., Stern D.F., Gullick W.J., and Salomon D.S. Cripto enhances the tyrosine phosphorylation of Shc and activates mitogen-activated protein kinase (MAPK) in mammary epithelial cells. J. Biol. Chem. 272 (1997) 3330-3335
97. Kenney N.J., Huang R.P., Johnson G.R., Wu J.X., Okamura D., Matheny W., Kordon E., Gullick W.J., Plowman G., Smith G.H., et al. Detection and location of amphiregulin and Cripto-1 expression in the developing postnatal mouse mammary gland. Mol. Reprod. Dev. 41 (1995) 277-286
98. Kenney N.J., Smith G.H., Maroulakou I.G., Green J.H., Muller W.J., Callahan R., Salomon D.S., and Dickson R.B. Detection of amphiregulin and Cripto-1 in mammary tumors from transgenic mice. Mol. Carcinog. 15 (1996) 44-56
99. Kenney N., Smith G., Johnson M., Rosemberg K., Salomon D.S., and Dickson R. Cripto-1 activity in the intact and ovariectomized virgin mouse mammary gland. Pathogenesis 1 (1997) 57-71
100. Kenney N.J., Adkins H.B., and Sanicola M. Nodal and cripto-1: Embryonic pattern formation genes involved in mammary gland development and tumorigenesis. J. Mammary Gland Biol. Neoplasia 9 (2004) 133-144
101. Kim B.C., van Gelder H., Kim T.A., Lee H.J., Baik K.G., Chun H.H., Lee D.A., Choi K.S., and Kim S.J. Activin receptor-like kinase-7 induces apoptosis through activation of MAPKs in a Smad3-dependent mechanism in hepatoma cells. J. Biol. Chem. 279 (2004) 28458-28465
102. Kinoshita N., Minshull J., and Kirschner M.W. The identification of two novel ligands of the FGF receptor by a yeast screening method and their activity in Xenopus development. Cell 83 (1995) 621-630
103. Klapper L.N., Kirschbaum M.H., Sela M., and Yarden Y. Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors. Adv. Cancer Res. 77 (2000) 25-79
104. Kleinberg D.L. Role of IGF-I in normal mammary development. Breast. Cancer Res. Treat. 47 (1998) 201-208
105. Kodjabachian L. Morphogen gradients: Nodal enters the stage. Curr. Biol. 11 (2001) R655-R658
106. Kopper L., and Hajdu M. Tumor stem cells. Pathol. Oncol. Res. 10 (2004) 69-73
107. Kuniyasu H., Yoshida K., Yokozaki H., Yasui W., Ito H., Toge T., Ciardiello F., Persico M.G., Saeki T., Salomon D.S., et al. Expression of cripto, a novel gene of the epidermal growth factor family, in human gastrointestinal carcinomas. Jpn. J. Cancer Res. 82 (1991) 969-973
108. Kuniyasu H., Yasui W., Akama Y., Akagi M., Tohdo H., Ji Z.Q., Kitadai Y., Yokozaki H., and Tahara E. Expression of cripto in human gastric carcinomas: An association with tumor stage and prognosis. J. Exp. Clin. Cancer Res. 13 (1994) 151-157
109. Liebner S., Cattelino A., Gallini R., Rudini N., Iurlaro M., Piccolo S., and Dejana E. Beta-catenin is required for endothelial-mesenchymal transformation during heart cushion development in the mouse. J. Cell. Biol. 166 (2004) 359-367
110. Liguori G., Tucci M., Montuori N., Dono R., Lago C.T., Pacifico F., Armenante F., and Persico M.G. Characterization of the mouse Tdgf1 gene and Tdgf pseudogenes. Mamm. Genome 7 (1996) 344-348
111. Liguori G., De Gregorio L., Tucci M., Lago C.T., Barra A., Dragani T.A., and Persico M. Mapping of the mouse Tdgf1 gene and Tdgf pseudogenes. Mamm. Genome 8 (1997) 502-505
112. Liu X., Lee J., Cooley M., Bhogte E., Hartley S., and Glick A. Smad7 but not Smad6 cooperates with oncogenic ras to cause malignant conversion in a mouse model for squamous cell carcinoma. Cancer Res. 63 (2003) 7760-7768
113. Lochter A. Plasticity of mammary epithelia during normal development and neoplastic progression. Biochem. Cell. Biol. 76 (1998) 997-1008
114. Lohmeyer M., Harrison P.M., Kannan S., DeSantis M., O'Reilly N.J., Sternberg M.J., Salomon D.S., and Gullick W.J. Chemical synthesis, structural modeling, and biological activity of the epidermal growth factor-like domain of human cripto. Biochemistry 36 (1997) 3837-3845
115. Maemura M., Akiyama S.K., Woods Jr. V.L., and Dickson R.B. Expression and ligand binding of alpha 2 beta 1 integrin on breast carcinoma cells. Clin. Exp. Metastasis 13 (1995) 223-235
116. Maroulakou I.G., Anver M., Garrett L., and Green J.E. Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene. Proc. Natl. Acad. Sci. USA 91 (1994) 11236-11240
117. McKendry R., Hsu S.C., Harland R.M., and Grosschedl R. LEF-1/TCF proteins mediate wnt-inducible transcription from the Xenopus nodal-related 3 promoter. Dev. Biol. 192 (1997) 420-431
118. Meinhardt H. Organizer and axes formation as a self-organizing process. Int. J. Dev. Biol. 45 (2001) 177-188
119. Minchiotti G., Parisi S., Liguori G., Signore M., Lania G., Adamson E.D., Lago C.T., and Persico M.G. Mech. Dev. 90 (2000) 133-142
120. Minchiotti G., Manco G., Parisi S., Lago C.T., Rosa F., and Persico M.G. Structure-function analysis of the EGF-CFC family member Cripto identifies residues essential for nodal signaling. Development 128 (2001) 4501-4510
121. Minchiotti G., Parisi S., Liguori G.L., D'Andrea D., and Persico M.G. Membrane-anchorage of Cripto protein by glycosylphosphatidylinositol and its distribution during early mouse development. Gene 287 (2002) 33-37
122. Mincione G., Piccirelli A., Lazzereschi D., Salomon D.S., and Colletta G. Heregulin-dependent autocrine loop regulates growth of K-ras but not erbB-2 transformed rat thyroid epithelial cells. J. Cell. Physiol. 176 (1998) 383-391
123. Mintz B., and Illmensee K. Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc. Natl. Acad. Sci. USA 72 (1975) 3585-3589
124. Morkel M., Huelsken J., Wakamiya M., Ding J., van de Wetering M., Clevers H., Taketo M.M., Behringer R.R., Shen M.M., and Birchmeier W. Beta-catenin regulates Cripto- and Wnt3-dependent gene expression programs in mouse axis and mesoderm formation. Development 130 (2003) 6283-6294
125. Muller W.J., Ho J., and Siegel P.M. Oncogenic activation of Neu/ErbB-2 in a transgenic mouse model for breast cancer. Biochem. Soc. Symp. 63 (1998) 149-157
126. Munir S., Xu G., Wu Y., Yang B., Lala P.K., and Peng C. Nodal and ALK7 inhibit proliferation and induce apoptosis in human trophoblast cells. J. Biol. Chem. 279 (2004) 31277-31286
127. Neckers L.M., Rosolen A., and Whitesell L. Antisense inhibition of gene expression: A tool for studying the role of NMYC in the growth and differentiation of neuroectoderm-derived cells. J. Immunother. 12 (1992) 162-166
128. Nelson W.J., and Nusse R. Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303 (2004) 1483-1487
129. Nickoloff B.J., Osborne B.A., and Miele L. Notch signaling as a therapeutic target in cancer: A new approach to the development of cell fate modifying agents. Oncogene 22 (2003) 6598-6608
130. Nieman M.T., Prudoff R.S., Johnson K.R., and Wheelock M.J. N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J. Cell. Biol. 147 (1999) 631-644
131. Niemeyer C.C., Persico M.G., and Adamson E.D. Cripto: Roles in mammary cell growth, survival, differentiation, and transformation. Cell. Death Differ. 5 (1998) 440-449
132. Niemeyer C.C., Spencer-Dene B., Wu J.X., and Adamson E.D. Preneoplastic mammary tumor markers: Cripto and Amphiregulin are overexpressed in hyperplastic stages of tumor progression in transgenic mice. Int. J. Cancer 81 (1999) 588-591
133. Niikura H., Sasano H., Kaga K., Sato S., and Yajima A. Expression of epidermal growth factor family proteins and epidermal growth factor receptor in human endometrium. Hum. Pathol. 27 (1996) 282-289
134. Niikura H., Sasano H., Sato S., and Yajima A. Expression of epidermal growth factor-related proteins and epidermal growth factor receptor in common epithelial ovarian tumors. Int. J. Gynecol. Pathol. 16 (1997) 60-68
135. Normanno N., Qi C.-F., Gullick W.J., Persico M.G., Yarden Y., Wen D., Plowman G., Kenney N., Johnson G.R., Kim N., Brandt R., Martinez-Lacaci I., Dickson R.B., and Salomon D.S. Expression of amphireguli, cripto-1, and heregulin in human breast cancer cells. Int. J. Oncol. 2 (1993) 903-911
136. Normanno N., Kim N., Wen D., Smith K., Harris A.L., Plowman G., Colletta G., Ciardiello F., and Salomon D.S. Expression of messenger RNA for amphiregulin, heregulin, and cripto-1, three new members of the epidermal growth factor family, in human breast carcinomas. Breast Cancer Res. Treat. 35 (1995) 293-297
137. Normanno N., Bianco C., Damiano V., de Angelis E., Selvam M.P., Grassi M., Magliulo G., Tortora G., Bianco A.R., Mendelsohn J., Salomon D.S., and Ciardiello F. Growth inhibition of human colon carcinoma cells by combinations of anti-epidermal growth factor-related growth factor antisense oligonucleotides. Clin. Cancer Res. 2 (1996) 601-609
138. Normanno N., Tortora G., De Luca A., Pomatico G., Casamassimi A., Agrawal S., Mendelsohn J., Bianco A.R., and Ciardiello F. Synergistic growth inhibition and induction of apoptosis by a novel mixed backbone antisense oligonucleotide targeting CRIPTO in combination with C225 anti-EGFR monoclonal antibody and 8-Cl-cAMP in human GEO colon cancer cells. Oncol. Rep. 6 (1999) 1105-1109
139. Normanno N., De Luca A., Bianco C., Maiello M.R., Carriero M.V., Rehman A., Wechselberger C., Arra C., Strizzi L., Sanicola M., and Salomon D.S. Cripto-1 overexpression leads to enhanced invasiveness and resistance to anoikis in human MCF-7 breast cancer cells. J. Cell. Physiol. 198 (2004) 31-39
140. Normanno N., De Luca A., Maiello M.R., Bianco C., Mancino M., Strizzi L., Arra C., Ciardiello F., Agrawal S., and Salomon D.S. Cripto-1: A novel target for therapeutic intervention in human carcinoma. Int. J. Oncol. 25 (2004) 1013-1020
141. Novak A., Hsu S.C., Leung-Hagesteijn C., Radeva G., Papkoff J., Montesano R., Roskelley C., Grosschedl R., and Dedhar S. Cell adhesion and the integrin-linked kinase regulate the LEF-1 and beta-catenin signaling pathways. Proc. Natl. Acad. Sci. USA 95 (1998) 4374-4379
142. Okajima T., and Irvine K.D. Regulation of notch signaling by o-linked fucose. Cell 111 (2002) 893-904
143. Panico L., D'Antonio A., Salvatore G., Mezza E., Tortora G., De Laurentiis M., De Placido S., Giordano T., Merino M., Salomon D.S., Mullick W.J., Pettinato G., Schnitt S.J., Bianco A.R., and Ciardiello F. Differential immunohistochemical detection of transforming growth factor alpha, amphiregulin, and CRIPTO in human normal and malignant breast tissues. Int. J. Cancer 65 (1996) 51-56
144. Parisi S., D'Andrea D., Lago C.T., Adamson E.D., Persico M.G., and Minchiotti G. Nodal-dependent Cripto signaling promotes cardiomyogenesis and redirects the neural fate of embryonic stem cells. J. Cell. Biol. 163 (2003) 303-314
145. Perez-Pomares J.M., and Munoz-Chapuli R. Epithelial-mesenchymal transitions: A mesodermal cell strategy for evolutive innovation in Metazoans. Anat. Rec. 268 (2002) 343-351
146. Persico M.G., Liguori G.L., Parisi S., D'Andrea D., Salomon D.S., and Minchiotti G. Cripto in tumors and embryo development. Biochim. Biophys. Acta 1552 (2001) 87-93
147. Pfeiffer D., Spranger J., Al-Deiri M., Kimmig R., Fisseler-Eckhoff A., Scheidel P., Schatz H., Jensen A., and Pfeiffer A. mRNA expression of ligands of the epidermal-growth-factor-receptor in the uterus. Int. J. Cancer 72 (1997) 581-586
148. Pierce G.B., and Speers W.C. Tumors as caricatures of the process of tissue renewal: Prospects for therapy by directing differentiation. Cancer Res. 48 (1988) 1996-2004
149. Polakis P. Wnt signaling and cancer. Genes Dev. 14 (2000) 1837-1851
150. Potter J.D. Morphostats: A missing concept in cancer biology. Cancer Epidemiol. Biomarkers Prev. 10 (2001) 161-170
151. Qi C.F., Liscia D.S., Normanno N., Merlo G., Johnson G.R., Gullick W.J., Ciardiello F., Saeki T., Brandt R., Kim N., et al. Expression of transforming growth factor alpha, amphiregulin, and cripto-1 in human breast carcinomas. Br. J. Cancer 69 (1994) 903-910
152. Rajevic U., Juvan R., Gazvoda B., Repse S., and Komel R. Assessment of differential expression of oncogenes in gastric adenocarcinoma by fluorescent multiplex RT-PCR assay. Pflugers Arch. 442 (2001) R190-R192
153. Ramalho-Santos M., Yoon S., Matsuzaki Y., Mulligan R.C., and Melton D.A. "Stemness": Transcriptional profiling of embryonic and adult stem cells. Science 298 (2002) 597-600
154. Reissmann E., Jornvall H., Blokzijl A., Andersson O., Chang C., Minchiotti G., Persico M.G., Ibanez C.F., and Brivanlou A.H. The orphan receptor ALK7 and the Activin receptor ALK4 mediate signaling by Nodal proteins during vertebrate development. Genes Dev. 15 (2001) 2010-2022
155. Robinson G.W. Identification of signaling pathways in early mammary gland development by mouse genetics. Breast Cancer Res. 6 (2004) 105-108
156. Rusch V., Klimstra D., Venkatraman E., Pisters P.W., Langenfeld J., and Dmitrovsky E. Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression. Clin. Cancer Res. 3 (1997) 515-522
157. Saccone S., Rapisarda A., Motta S., Dono R., Persico G.M., and Della Valle G. Regional localization of the human EGF-like growth factor CRIPTO gene (TDGF-1) to chromosome 3p21. Hum. Genet. 95 (1995) 229-230
158. Saeki T., Stromberg K., Qi C.F., Gullick W.J., Tahara E., Normanno N., Ciardiello F., Kenney N., Johnson G.R., and Salomon D.S. Differential immunohistochemical detection of amphiregulin and cripto in human normal colon and colorectal tumors. Cancer Res. 52 (1992) 3467-3473
159. Saeki T., Salomon D.S., Normanno N., Johnson G.R., Gullick W.J., Mandai K., Moriwaki S., Takashima S., Kuniyasu M., Tahara E., Kawami M., Nishiyama M., and Toge T. Immunohistochemical detection of cripto-1-, amphiregulin, and transforming growth factor alpha in human gastric carcinomas and intestinal metaplasias. Int. J. Onc. 5 (1994) 215-223
160. Saeki T., Salomon D.S., Gullick W.J., Mandai K., Yamagami K., Moriwaki S., Takashima S., Nishikawa Y., and Tahara E. Expression of cripto-1 in human colorectal adenomas and carcinomas is related to degree of dysplasia. Int. J. Oncol. 5 (1994) 445-452
161. Saeki T., Salomon D.S., Johnson G.R., Gullick W.J., Mandai K., Yamagami K., Moriwaki S., Tanada M., Takashima S., and Tahara E. Association of epidermal growth factor-related peptides and type I receptor tyrosine kinase receptors with prognosis of human colorectal carcinomas. Jpn. J. Clin. Oncol. 25 (1995) 240-249
162. Saijoh Y., Adachi H., Sakuma R., Yeo C.Y., Yashiro K., Watanabe M., Hashiguchi H., Mochida K., Ohishi S., Kawabata M., Miyazono K., Whitman M., and Hamada H. Left-right asymmetric expression of lefty2 and nodal is induced by a signaling pathway that includes the transcription factor FAST2. Mol. Cell 5 (2000) 35-47
163. Sakuma R., Ohnishi Yi Y., Meno C., Fujii H., Juan H., Takeuchi J., Ogura T., Li E., Miyazono K., and Hamada H. Inhibition of Nodal signalling by Lefty mediated through interaction with common receptors and efficient diffusion. Genes Cells 7 (2002) 401-412
164. Salomon D.S., Bianco C., and De Santis M. Cripto: A novel epidermal growth factor (EGF)-related peptide in mammary gland development and neoplasia. Bioessays 21 (1999) 61-70
165. Salomon D.S., Bianco C., Ebert A.D., Khan N.I., De Santis M., Normanno N., Wechselberger C., Seno M., Williams K., Sanicola M., Foley S., Gullick W.J., and Persico G. The EGF-CFC family: Novel epidermal growth factor-related proteins in development and cancer. Endocr. Relat. Cancer 7 (2000) 199-226
166. Sato N., Sanjuan I.M., Heke M., Uchida M., Naef F., and Brivanlou A.H. Molecular signature of human embryonic stem cells and its comparison with the mouse. Dev. Biol. 260 (2003) 404-413
167. Savagner P. Leaving the neighborhood: Molecular mechanisms involved during epithelial-mesenchymal transition. Bioessays 23 (2001) 912-923
168. Schier A.F., and Shen M.M. Nodal signalling in vertebrate development. Nature 403 (2000) 385-389
169. Schier A.F., and Talbot W.S. Nodal signaling and the zebrafish organizer. Int. J. Dev. Biol. 45 (2001) 289-297
170. Schier A.F. Nodal signaling in vertebrate development. Annu. Rev. Cell. Dev. Biol. 19 (2003) 589-621
171. Schiffer S.G., Foley S., Kaffashan A., Hronowski X., Zichittella A.E., Yeo C.Y., Miatkowski K., Adkins H.B., Damon B., Whitman M., Salomon D., Sanicola M., and Williams K.P. Fucosylation of Cripto is required for its ability to facilitate nodal signaling. J. Biol. Chem. 276 (2001) 37769-37778
172. Schlange T., Schnipkoweit I., Andree B., Ebert A., Zile M.H., Arnold H.H., and Brand T. Chick CFC controls Lefty1 expression in the embryonic midline and nodal expression in the lateral plate. Dev. Biol. 234 (2001) 376-389
173. Scognamiglio B., Baldassarre G., Cassano C., Tucci M., Montuori N., Dono R., Lembo G., Barra A., Lago C.T., Viglietto G., Rocchi M., and Persico M.G. Assignment of human teratocarcinoma derived growth factor (TDGF) sequences to chromosomes 2q37, 3q22, 6p25, and 19q13.1. Cytogenet. Cell. Genet. 84 (1999) 220-224
174. Sekido Y., Ahmadian M., Wistuba I., L., F., Bader S., Wei M.H., Duh F.M., Gazdar A.F., Lerman M.I., and Minna J.D. Cloning of a breast cancer homozygous deletion junction narrows the region of search for a 3p21.3 tumor suppressor gene. Oncogene 16 (1998) 3151-3157
175. Sell S., and Pierce G.B. Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers. Lab. Invest. 70 (1994) 6-22
176. Sell S. Stem cell origin of cancer and differentiation therapy. Crit. Rev. Oncol. Hematol. 51 (2004) 1-28
177. Seno M., DeSantis M., Kannan S., Bianco C., Tada H., Kim N., Kosaka M., Gullick W.J., Yamada H., and Salomon D.S. Purification and characterization of a recombinant human cripto-1 protein. Growth Factors 15 (1998) 215-229
178. Shen M.M., Wang H., and Leder P. A differential display strategy identifies Cryptic, a novel EGF-related gene expressed in the axial and lateral mesoderm during mouse gastrulation. Development 124 (1997) 429-442
179. Shen M.M., and Schier A.F. The EGF-CFC gene family in vertebrate development. Trends Genet. 16 (2000) 303-309
180. Sirard C., de la Pompa J.L., Elia A., Itie A., Mirtsos C., Cheung A., Hahn S., Wakeham A., Schwartz L., Kern S.E., Rossant J., and Mak T.W. The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo. Genes Dev. 12 (1998) 107-119
181. Spencer-Dene B., Dillon C., Fantl V., Kerr K., Petiot A., and Dickson C. Fibroblast growth factor signalling in mouse mammary gland development. Endocr. Relat. Cancer 8 (2001) 211-217
182. Sporn M.B., and Roberts A.B. Autocrine secretion - 10 years later. Ann. Intern. Med. 117 (1992) 408-414
183. Srinivasan R., Gillett C.E., Barnes D.M., and Gullick W.J. Nuclear expression of the c-erbB-4/HER-4 growth factor receptor in invasive breast cancers. Cancer Res. 60 (2000) 1483-1487
184. Steinert P.M., and Roop D.R. Molecular and cellular biology of intermediate filaments. Annu. Rev. Biochem. 57 (1988) 593-625
185. Strizzi L., Bianco C., Normanno N., Seno M., Wecheselberger C., Wallace-Jones B., Khan N.I., Hirota M., Sun Y., Sanicola M., and Salomon D.S. Epithelial mesenchymal transition is a characteristic of hyperplasias and tumors in mammary gland from MMTV-Cripto-1 transgenic mice. J. Cell. Physiol. 201 (2004) 266-276
186. Stromberg K., Johnson G.R., O'Connor D.M., Sorensen C.M., Gullick W.J., and Kannan B. Frequent immunohistochemical detection of EGF supergene family members in ovarian carcinogenesis. Int. J. Gynecol. Pathol. 13 (1994) 342-347
187. Su Z.Z., Austin V.N., Zimmer S.G., and Fisher P.B. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells. Oncogene 8 (1993) 1211-1219
188. Tabata T., and Takei Y. Morphogens, their identification, and regulation. Development 131 (2004) 703-712
189. Tanegashima K., Haramoto Y., Yokota C., Takahashi S., and Asashima M. Xantivin suppresses the activity of EGF-CFC genes to regulate nodal signaling. Int. J. Dev. Biol. 48 (2004) 275-283
190. Thayer S.P., di Magliano M.P., Heiser P.W., Nielsen C.M., Roberts D.J., Lauwers G.Y., Qi Y.P., Gysin S., Fernandez-del Castillo C., Yajnik V., Antoniu B., McMahon M., Warshaw A.L., and Hebrok M. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 425 (2003) 851-856
191. Thiery J.P., and Chopin D. Epithelial cell plasticity in development and tumor progression. Cancer Metastasis Rev. 18 (1999) 31-42
192. Thiery J.P. Epithelial-mesenchymal transitions in tumor progression. Nat. Rev. Cancer 2 (2002) 442-454
193. Todd M.C., Xiang R.H., Garcia D.K., Kerbacher K.E., Moore S.L., Hensel C.H., Liu P., Siciliano M.J., Kok K., van den Berg A., Veldhuis P., Buys C.H., Killary A.M., and Naylor S.L. An 80 Kb P1 clone from chromosome 3p21.3 suppresses tumor growth in vivo. Oncogene 13 (1996) 2387-2396
194. Tsutsumi M., Yasui W., Naito A., Ohashi K., Kobayashi E., Noguchi O., Horiguchi K., Okita S., Tsujiuchi T., Kitada H., et al. Expression of cripto in human pancreatic tumors. Jpn. J. Cancer Res. 85 (1994) 118-121
195. Uchida T., Wada K., Akamatsu T., Yonezawa M., Noguchi H., Mizoguchi A., Kasuga M., and Sakamoto C. A novel epidermal growth factor-like molecule containing two follistatin modules stimulates tyrosine phosphorylation of erbB-4 in MKN28 gastric cancer cells. Biochem. Biophys. Res. Commun. 266 (1999) 593-602
196. Vallier L., Reynolds D., and Pedersen R.A. Nodal inhibits differentiation of human embryonic stem cells along the neuroectodermal default pathway. Dev. Biol. 275 (2004) 403-421
197. van Vlijmen H.W., Gupta A., Narasimhan L.S., and Singh J. A novel database of disulfide patterns and its application to the discovery of distantly related homologs. J. Mol. Biol. 335 (2004) 1083-1092
198. Wacker S., Brodbeck A., Lemaire P., Niehrs C., and Winklbauer R. Patterns and control of cell motility in the Xenopus gastrula. Development 125 (1998) 1931-1942
199. Waldrip W.R., Bikoff E.K., Hoodless P.A., Wrana J.L., and Robertson E.J. Smad2 signaling in extraembryonic tissues determines anterior-posterior polarity of the early mouse embryo. Cell 92 (1998) 797-808
200. Wang H., Cai Q., Zeng X., Yu D., Agrawal S., and Zhang R. Antitumor activity and pharmacokinetics of a mixed-backbone antisense oligonucleotide targeted to the RIalpha subunit of protein kinase A after oral administration. Proc. Natl. Acad. Sci. USA 96 (1999) 13989-13994
201. Warga R.M., and Kane D.A. One-eyed pinhead regulates cell motility independent of Squint/Cyclops signaling. Dev. Biol. 261 (2003) 391-411
202. Wechselberger C., Ebert A.D., Bianco C., Khan N.I., Sun Y., Wallace-Jones B., Montesano R., and Salomon D.S. Cripto-1 enhances migration and branching morphogenesis of mouse mammary epithelial cells. Exp. Cell. Res. 266 (2001) 95-105
203. Weinberg R.A. Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Res. 49 (1989) 3713-3721
204. Welss T., Papoutsaki M., Michel G., Reifenberger J., Chimenti S., Ruzicka T., and Abts H.F. Molecular basis of basal cell carcinoma: Analysis of differential gene expression by differential display PCR and expression array. Int. J. Cancer 104 (2003) 66-72
205. Xing P.X., Hu X.F., Pietersz G.A., Hosick H.L., and McKenzie I.F. Cripto: A novel target for antibody-based cancer immunotherapy. Cancer Res. 64 (2004) 4018-4023
206. Xu C., Liguori G., Adamson E.D., and Persico M.G. Specific arrest of cardiogenesis in cultured embryonic stem cells lacking Cripto-1. Dev. Biol. 196 (1998) 237-247
207. Xu C., Liguori G., Persico M.G., and Adamson E.D. Abrogation of the Cripto gene in mouse leads to failure of postgastrulation morphogenesis and lack of differentiation of cardiomyocytes. Development 126 (1999) 483-494
208. Yabe S., Tanegashima K., Haramoto Y., Takahashi S., Fujii T., Kozuma S., Taketani Y., and Asashima M. FRL-1, a member of the EGF-CFC family, is essential for neural differentiation in Xenopus early development. Development 130 (2003) 2071-2081
209. Yan Y.T., Gritsman K., Ding J., Burdine R.D., Corrales J.D., Price S.M., Talbot W.S., Schier A.F., and Shen M.M. Conserved requirement for EGF-CFC genes in vertebrate left-right axis formation. Genes Dev. 13 (1999) 2527-2537
210. Yan Y.T., Liu J.J., Luo Y., E.C., Haltiwanger R.S., Abate-Shen C., and Shen M.M. Dual roles of Cripto as a ligand and coreceptor in the nodal signaling pathway. Mol. Cell. Biol. 22 (2002) 4439-4449
211. Yeo C., and Whitman M. Nodal signals to Smads through Cripto-dependent and Cripto-independent mechanisms. Mol. Cell 7 (2001) 949-957
212. Yokota C., Kofron M., Zuck M., Houston D.W., Isaacs H., Asashima M., Wylie C.C., and Heasman J. A novel role for a nodal-related protein; Xnr3 regulates convergent extension movements via the FGF receptor. Development 130 (2003) 2199-2212
213. Zeng X., Miura T., Luo Y., Bhattacharya B., Condie B., Chen J., Ginis I., Lyons I., Mejido J., Puri R.K., Rao M.S., and Freed W.J. Properties of pluripotent human embryonic stem cells BG01 and BG02. Stem Cells 22 (2004) 292-312
214. Zhang J., Talbot W.S., and Schier A.F. Positional cloning identifies zebrafish one-eyed pinhead as a permissive EGF-related ligand required during gastrulation. Cell 92 (1998) 241-251